I agree that this site is using cookies. You can find further informations here.
X
Frohna, Paul
66  results:
Search for persons X
?
1

Vγ9Vδ2 T-cells Are Potent Inhibitors of SARS-CoV-2 Replicat..:

Gay, Laetitia ; Rouviere, Marie-Sarah ; Mezouar, Soraya...
The Journal of Infectious Diseases.  229 (2024)  6 - p. 1759-1769 , 2024
Link: https://doi.org/10.1093/..
 
?
2

Role of Vγ9vδ2 T lymphocytes in infectious diseases:

Gay, Laetitia ; Mezouar, Soraya ; Cano, Carla...
Frontiers in Immunology.  13 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
3

RPC4046, a Monoclonal Antibody Against IL13, Reduces Histol..:

Hirano, Ikuo ; Collins, Margaret H. ; Assouline-Dayan, Yehudith...
Gastroenterology.  156 (2019)  3 - p. 592-603.e10 , 2019
Link: https://doi.org/10.1053/..
 
?
4

Results From a First‐in‐Human Study of BNZ‐1, a Selective M..:

Frohna, Paul A. ; Ratnayake, Anoshie ; Doerr, Nick...
The Journal of Clinical Pharmacology.  60 (2019)  2 - p. 264-273 , 2019
Link: https://doi.org/10.1002/..
 
?
5

Efficacy and safety of ozanimod in multiple sclerosis: Dose..:

Cohen, Jeffrey A ; Comi, Giancarlo ; Arnold, Douglas L...
Multiple Sclerosis Journal.  25 (2018)  9 - p. 1255-1262 , 2018
Link: https://doi.org/10.1177/..
 
?
6

Ozanimod (RPC1063) Reduces Plasma Levels of Neurofilament L..:

Meadows, Kristen Taylor ; Skolnick, Brett ; Frohna, Paul...
Neurology.  90 (2018)  15_supplement - p. , 2018
Link: https://doi.org/10.1212/..
 
?
7

Efficacy and Safety of Ozanimod: Results From the 2-Year Bl..:

Cohen, Jeffrey ; Selmaj, Krzysztof ; Arnold, Douglas...
Neurology.  88 (2017)  16_supplement - p. , 2017
Link: https://doi.org/10.1212/..
 
?
8

UB‐311, a novel UBITh® amyloid β peptide vaccine for mild A..:

Wang, Chang Yi ; Wang, Pei‐Ning ; Chiu, Ming‐Jang...
Alzheimer's & Dementia: Translational Research & Clinical Interventions.  3 (2017)  2 - p. 262-272 , 2017
Link: https://doi.org/10.1016/..
 
?
9

Results From the First‐in‐Human Study With Ozanimod, a Nove..:

Tran, Jonathan Q. ; Hartung, Jeffrey P. ; Peach, Robert J....
The Journal of Clinical Pharmacology.  57 (2017)  8 - p. 988-996 , 2017
Link: https://doi.org/10.1002/..
 
?
10

Cardiac Safety of Ozanimod, a Novel Sphingosine‐1‐Phosphate..:

Tran, Jonathan Q. ; Hartung, Jeffrey P. ; Olson, Allan D....
Clinical Pharmacology in Drug Development.  7 (2017)  3 - p. 263-276 , 2017
Link: https://doi.org/10.1002/..
 
?
11

Effects of High‐ and Low‐Fat Meals on the Pharmacokinetics ..:

Tran, Jonathan Q. ; Hartung, Jeffrey P. ; Tompkins, Cindy‐Ann.
Clinical Pharmacology in Drug Development.  7 (2017)  6 - p. 634-640 , 2017
Link: https://doi.org/10.1002/..
 
?
12

Safety and efficacy of the selective sphingosine 1-phosphat..:

Cohen, Jeffrey A ; Arnold, Douglas L ; Comi, Giancarlo...
The Lancet Neurology.  15 (2016)  4 - p. 373-381 , 2016
Link: https://doi.org/10.1016/..
 
?
13

P-106 Examination of an Alternative Definition for Clinical..:

Sandborn, William ; Feagan, Brian ; D'Haens, Geert...
Inflammatory Bowel Diseases.  22 (2016)  - p. S43 , 2016
Link: https://doi.org/10.1097/..
 
?
14

857 Ozanimod Induces Histological Response and Remission: R..:

Sandborn, William ; Feagan, Brian G. ; D'Haens, Geert R....
Gastroenterology.  150 (2016)  4 - p. S183 , 2016
Link: https://doi.org/10.1016/..
 
?
15

Results from the 48-Week Blinded Extension of RADIANCE: A R..:

Selmaj, Krzysztof ; Cohen, Jeffrey ; Arnold, Douglas...
Neurology.  86 (2016)  16_supplement - p. , 2016
Link: https://doi.org/10.1212/..
 
1-15